Lilly overtakes rival J&J in market cap to become world's most valuable drugmaker – Indianapolis Business Journal

Eli Lilly and Co. shares have soared 57% over the past 52 weeks, buoyed in part by sales of its diabetes drug Mounjaro, which the company is also preparing to seek approval to market for obesity.

Related Keywords

Evan David Siegerman ,Eli Lilly ,Novartis ,Pfizer Inc ,Johnson ,Pfizer ,Merck Co ,New Brunswick ,New Jersey Based Johnson ,David Siegerman ,Swiss Based Roche ,New Jersey Based Merck ,Illinois Based Abbvie ,